---
figid: PMC4100437__BMRI2014-890141.001
figlink: /pmc/articles/PMC4100437/figure/fig1/
number: F1
caption: A hypothetical model of chemoresistance in human ovarian cancer cells. In
  a chemosensitive ovarian cancer cell (a), cisplatin activates p53, leading to upregulation
  of proteins promoting cell cycle arrest, such as p21, and of proapoptotic proteins
  such as Bax and Fas. This activates both the intrinsic (mitochondrial) and the extrinsic
  (death-receptor) apoptotic pathways, the overall result of which is the activation
  of the execution caspase-3 (and caspase-7, not shown). In these cells, cell survival
  mediators such as Xiap, Akt, and Flip (shown in red) are downregulated or are in
  their inactive state. In chemoresistant cells (b), increased p53 ubiquitination
  by MDM2 results in the maintenance of low levels of p53, despite the presence of
  cisplatin. Moreover, cisplatin fails to downregulate Xiap, thereby maintaining an
  active state of the PI3K/Akt pathway. In addition, binding of TNFR2 by TNFα leads
  to upregulation of FLIP through the NF-κB pathway, thus inhibiting the proapoptotic
  actions of the cytokine through TNFR1. Overall, as a consequence of a failure to
  activate the caspase cascade in response to the chemotherapeutic agent, these cells
  have lost their capacity to undergo apoptosis and thus became chemoresistant. Taken
  from [].
pmcid: PMC4100437
papertitle: 'Phytochemicals: A Multitargeted Approach to Gynecologic Cancer Therapy.'
reftext: Lee Farrand, et al. Biomed Res Int. 2014;2014:890141.
pmc_ranked_result_index: '19508'
pathway_score: 0.9554043
filename: BMRI2014-890141.001.jpg
figtitle: Hypothetical model of chemoresistance in human ovarian cancer cells
year: '2014'
organisms:
- Homo sapiens
ndex: c85f6542-deea-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4100437__BMRI2014-890141.001.html
  '@type': Dataset
  description: A hypothetical model of chemoresistance in human ovarian cancer cells.
    In a chemosensitive ovarian cancer cell (a), cisplatin activates p53, leading
    to upregulation of proteins promoting cell cycle arrest, such as p21, and of proapoptotic
    proteins such as Bax and Fas. This activates both the intrinsic (mitochondrial)
    and the extrinsic (death-receptor) apoptotic pathways, the overall result of which
    is the activation of the execution caspase-3 (and caspase-7, not shown). In these
    cells, cell survival mediators such as Xiap, Akt, and Flip (shown in red) are
    downregulated or are in their inactive state. In chemoresistant cells (b), increased
    p53 ubiquitination by MDM2 results in the maintenance of low levels of p53, despite
    the presence of cisplatin. Moreover, cisplatin fails to downregulate Xiap, thereby
    maintaining an active state of the PI3K/Akt pathway. In addition, binding of TNFR2
    by TNFα leads to upregulation of FLIP through the NF-κB pathway, thus inhibiting
    the proapoptotic actions of the cytokine through TNFR1. Overall, as a consequence
    of a failure to activate the caspase cascade in response to the chemotherapeutic
    agent, these cells have lost their capacity to undergo apoptosis and thus became
    chemoresistant. Taken from [].
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CASP5
  - CASP1
  - CASP3
  - CASP4
  - CASP7
  - TP53
  - E2F2
  - CASP2
  - MDM2
  - AKT2
  - CASP8
  - CASP12
  - CASP6
  - CFLAR
  - E2F4
  - E2F3
  - E2F7
  - E2F6
  - CASP10
  - TNFRSF1A
  - TNFRSF1B
  - BIRC7
  - CASP14
  - AKT1
  - CASP9
  - E2F5
  - AKT3
  - CDK6
  - BAX
  - E2F8
  - E2F1
  - CDK4
  - FAS
  - XIAP
  - PTK2
  - Cisplatin
genes:
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP5
  entrez: '838'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP1
  entrez: '834'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP3
  entrez: '836'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP4
  entrez: '837'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP7
  entrez: '840'
- word: p53
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: -E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F2
  entrez: '1870'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP2
  entrez: '835'
- word: MDM2
  symbol: MDM2
  source: hgnc_symbol
  hgnc_symbol: MDM2
  entrez: '4193'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP8
  entrez: '841'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP12
  entrez: '100506742'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP6
  entrez: '839'
- word: FLIP
  symbol: FLIP
  source: hgnc_alias_symbol
  hgnc_symbol: CFLAR
  entrez: '8837'
- word: -E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F4
  entrez: '1874'
- word: -E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F3
  entrez: '1871'
- word: -E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F7
  entrez: '144455'
- word: -E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F6
  entrez: '1876'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP10
  entrez: '843'
- word: TNFR1
  symbol: TNFR1
  source: hgnc_prev_symbol
  hgnc_symbol: TNFRSF1A
  entrez: '7132'
- word: TNFR2
  symbol: TNF-R-II
  source: hgnc_alias_symbol
  hgnc_symbol: TNFRSF1B
  entrez: '7133'
- word: KIAP
  symbol: KIAP
  source: hgnc_alias_symbol
  hgnc_symbol: BIRC7
  entrez: '79444'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP14
  entrez: '23581'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP9
  entrez: '842'
- word: -E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F5
  entrez: '1875'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: TNFRI
  symbol: TNF-R-I
  source: hgnc_alias_symbol
  hgnc_symbol: TNFRSF1A
  entrez: '7132'
- word: cdk4/6
  symbol: CDK6
  source: hgnc_symbol
  hgnc_symbol: CDK6
  entrez: '1021'
- word: Bax
  symbol: BAX
  source: hgnc_symbol
  hgnc_symbol: BAX
  entrez: '581'
- word: -E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F8
  entrez: '79733'
- word: -E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F1
  entrez: '1869'
- word: cdk4/6
  symbol: CDK4
  source: hgnc_symbol
  hgnc_symbol: CDK4
  entrez: '1019'
- word: Fas
  symbol: FAS
  source: hgnc_symbol
  hgnc_symbol: FAS
  entrez: '355'
- word: XIAP
  symbol: XIAP
  source: hgnc_symbol
  hgnc_symbol: XIAP
  entrez: '331'
- word: FAK
  symbol: FAK
  source: hgnc_alias_symbol
  hgnc_symbol: PTK2
  entrez: '5747'
chemicals:
- word: Cisplatin
  source: MESH
  identifier: D002945
diseases: []
figid_alias: PMC4100437__F1
redirect_from: /figures/PMC4100437__F1
figtype: Figure
---
